Trump’s quest for Greenland could make Ozempic even more expensive
CNN
President-elect Donald Trump’s quest to buy Greenland from Denmark could make Ozempic and Wegovy, the weight-loss and diabetes drugs exploding in popularity, even more expensive for Americans.
President-elect Donald Trump’s quest to buy Greenland from Denmark could make Ozempic and Wegovy, the weight-loss and diabetes drugs exploding in popularity, even more expensive for Americans. Trump has cranked up the pressure on Danish officials to sell the strategically important North American island, turning to his go-to tactic: Threatening tariffs. Massive ones. During a press conference on Monday, Trump vowed to slap “very high” tariffs on Denmark if it doesn’t sell the island to the United States. Greenland is a self-governing entity inside Denmark’s kingdom. (Trump also declined to rule out military force to seize Greenland.) Broadly speaking, high tariffs on Denmark might not cause significant trouble for American consumers because Denmark is not a huge trading partner with the United States. Danish goods account for less than half of 1% of total US imports. However, the United States did import around $5.7 billion worth of pharmaceutical products from Denmark in 2023, according to the most recent annual United Nations trade data compiled by Trading Economics. That figure is likely even higher for 2024 because Novo Nordisk, the Danish pharmaceutical giant, makes one of the hottest drugs on the market: Ozempic.
Run 3 Space | Play Space Running Game
Traffic Jam 3D | Online Racing Game
Duck Hunt | Play Old Classic Game
Shari Redstone, the media mogul who has been trying to sell Paramount in a politically fraught transaction, is undergoing treatment for cancer.
President Trump, the poster-in-chief, may have finally been outposted — by the owner of the social media platform he used to love.
In the early days of President Donald Trump’s second term in office, federal websites went dark and data disappeared as the newly formed Department of Government Efficiency set its sights on streamlining the government.
Anna Gomez, soon to be the lone Democrat on the Federal Communications Commission, has been sounding the alarm about President Trump’s “weaponization” of her agency against the press. And now she’s taking it on the road.
UnitedHealthcare sued The Guardian on Wednesday for defamation, claiming the British daily ran information it knew to be incorrect in order to “capitalize” on its CEO’s assassination.
Despite widespread concerns that the trade war is dragging down America’s economy, President Donald Trump has notched quite a few wins on his economic belt in recent weeks.
Economists expect that the May jobs report could point to a softening labor market as hiring continues to slow amid economic uncertainty.
It’s a big day for Nintendo fans. The gaming giant’s new console, the $450 Switch 2, arrives on store shelves globally after being announced in April — marking Nintendo’s first major console launch since the original Switch arrived roughly eight years ago.
The European Central Bank on Thursday cut its main interest rate again, citing falling inflation.
Hooters has abruptly closed dozens of locations just a few months after the chicken wing chain filed for bankruptcy and proclaimed it wasn’t “going anywhere.”
Procter & Gamble said Thursday it would cut 7,000 jobs or about 6% of its total workforce over the next two years, as part of a new restructuring plan to counter uneven consumer demand and higher costs due to tariff uncertainty.
The European Union has urged China to ease restrictions on rare earth materials – critical for everything from cars to washing machines – after Beijing’s export controls disrupted supplies and triggered production turmoil across industries in Europe and America.
American businesses are fed up with President Donald Trump’s major